ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för teniposide. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

23 träffar

Bibliografisk träff 2020-02-03

SCF<sup>β-TrCP</sup>-mediated degradation of TOP2β promotes cancer cell survival in response to chemotherapeutic drugs targeting topoisomerase II.

Shu J, Cui D, Ma Y, Xiong X, Sun Y, Zhao Y.

Oncogenesis · research-article; journal article · DOI 10.1038/s41389-020-0196-1

Bibliografisk träff 2020-01-22

Curative effect of methotrexate combined with teniposide in the treatment of primary central nervous system lymphoma.

Wang YX, Huang Y, Xu XP, Chen BB, Lin ZG, Ma Y, Ding TL, Wang Q.

Oncol Lett · research-article; journal article · DOI 10.3892/ol.2020.11328

Bibliografisk träff 2018-11-05

Teniposide regulates the phenotype switching of vascular smooth muscle cells in a miR-21-dependent manner.

Han H, Yang S, Liang Y, Zeng P, Liu L, Yang X, Duan Y, Han J, Chen Y.

Biochem Biophys Res Commun · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bbrc.2018.10.198

Bibliografisk träff 2016-09-03

Preparation and evaluation of teniposide-loaded polymeric micelles for breast cancer therapy.

Chu B, Shi S, Li X, Hu L, Shi L, Zhang H, Xu Q, Ye L, Lin G, Zhang N, Zhang X.

Int J Pharm · comparative study; journal article · DOI 10.1016/j.ijpharm.2016.09.005

Bibliografisk träff 2015-08-04

Cremophor-free intravenous self-microemulsions for teniposide: Safety, antitumor activity in vitro and in vivo.

He S, Cui Z, Wang X, Zhang H, Dai W, Zhang Q.

Int J Pharm · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ijpharm.2015.08.005

Bibliografisk träff 2015-04-18

Encapsulation of teniposide into albumin nanoparticles with greatly lowered toxicity and enhanced antitumor activity.

He X, Xiang N, Zhang J, Zhou J, Fu Y, Gong T, Zhang Z.

Int J Pharm · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ijpharm.2015.04.047

Bibliografisk träff 2014-11-13

Preparation and in vitro-in vivo evaluation of teniposide nanosuspensions.

He S, Yang H, Zhang R, Li Y, Duan L.

Int J Pharm · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ijpharm.2014.11.020

Bibliografisk träff 2014-08-25

MiR-181b sensitizes glioma cells to teniposide by targeting MDM2.

Sun YC, Wang J, Guo CC, Sai K, Wang J, Chen FR, Yang QY, Chen YS, Wang J, To TS, Zhang ZP, Mu YG, Chen ZP.

BMC Cancer · research support, non-u.s. gov't; research-article; journal article · DOI 10.1186/1471-2407-14-611

Bibliografisk träff 2014-01-01

Fotemustine, teniposide and dexamethasone in treating patients with CNS lymphoma.

Wu JJ, Wang XH, Li L, Li X, Zhang L, Sun ZC, Fu XR, Ma W, Chang Y, Zhang XD, Han LJ, Zhang MZ.

Asian Pac J Cancer Prev · comparative study; research support, non-u.s. gov't; journal article · DOI 10.7314/apjcp.2014.15.11.4733

Bibliografisk träff 2013-07-06

Structural studies of several clinically important oncology drugs in complex with human serum albumin.

Wang ZM, Ho JX, Ruble JR, Rose J, Rüker F, Ellenburg M, Murphy R, Click J, Soistman E, Wilkerson L, Carter DC.

Biochim Biophys Acta · journal article · DOI 10.1016/j.bbagen.2013.06.032

Bibliografisk träff 2013-05-16

Reversal of multidrug resistance by mitochondrial targeted self-assembled nanocarrier based on stearylamine.

Zhang Z, Liu Z, Ma L, Jiang S, Wang Y, Yu H, Yin Q, Cui J, Li Y.

Mol Pharm · research support, non-u.s. gov't; journal article · DOI 10.1021/mp400039j

Bibliografisk träff 2013-03-01

DNA topoisomerase II inhibitors induce macrophage ABCA1 expression and cholesterol efflux-an LXR-dependent mechanism.

Zhang L, Jiang M, Shui Y, Chen Y, Wang Q, Hu W, Ma X, Li X, Liu X, Cao X, Liu M, Duan Y, Han J.

Biochim Biophys Acta · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bbalip.2013.02.007

Bibliografisk träff 2012-12-20

A self-assembled nanocarrier loading teniposide improves the oral delivery and drug concentration in tumor.

Zhang Z, Ma L, Jiang S, Liu Z, Huang J, Chen L, Yu H, Li Y.

J Control Release · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jconrel.2012.12.018

Bibliografisk träff 2012-07-28

Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.

Mo L, Hou L, Guo D, Xiao X, Mao P, Yang X.

Int J Pharm · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ijpharm.2012.07.050

Bibliografisk träff 2012-07-04

Knockdown of AKT2 expression by RNA interference inhibits proliferation, enhances apoptosis, and increases chemosensitivity to the anticancer drug VM-26 in U87 glioma cells.

Cui Y, Wang Q, Wang J, Dong Y, Luo C, Hu G, Lu Y.

Brain Res · research support, non-u.s. gov't; journal article · DOI 10.1016/j.brainres.2012.06.043

Bibliografisk träff 2012-05-30

A cremophor-free self-microemulsified delivery system for intravenous injection of teniposide: evaluation in vitro and in vivo.

He S, Cui Z, Mei D, Zhang H, Wang X, Dai W, Zhang Q.

AAPS PharmSciTech · research support, non-u.s. gov't; research-article; journal article · DOI 10.1208/s12249-012-9809-0

Bibliografisk träff 2011-08-06

Molecular cytogenetic evaluation of the aneugenic effects of teniposide in somatic and germinal cells of male mice.

Attia SM.

Mutagenesis · research support, non-u.s. gov't; journal article · DOI 10.1093/mutage/ger051

Bibliografisk träff 2011-03-23

Salubrious effects of dexrazoxane against teniposide-induced DNA damage and programmed cell death in murine marrow cells.

Bakheet SA, Attia SM, Al-Rasheed NM, Al-Harbi MM, Ashour AE, Korashy HM, Abd-Allah AR, Saquib Q, Al-Khedhairy AA, Musarrat J.

Mutagenesis · research support, non-u.s. gov't; journal article · DOI 10.1093/mutage/ger013

Bibliografisk träff 2001-06-01

Evaluation of teniposide (VM-26)-induced toxicity on mouse spermatogenesis by flow cytometry.

Jyothi P, Jagetia GC, Krishnamurthy H.

Toxicology · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1016/s0300-483x(01)00394-8

Bibliografisk träff 1992-04-01

Phase I study of oral teniposide (VM-26).

Smit EF, Ousterhuis BE, Berendsen HH, Sleijfer DT, Postmus PE.

Semin Oncol · journal article

Bibliografisk träff 1992-04-01

Teniposide (VM-26) in brain tumors.

McVie JG.

Semin Oncol · review; journal article

Bibliografisk träff 1992-04-01

Teniposide (VM-26) in ovarian cancer: a review.

van der Gaast A, Splinter TA.

Semin Oncol · review; journal article

Bibliografisk träff 1976-03-01

Phase I-II trial of VM-26 (NSC-122819) in the treatment of children with late-stage leukemia.

Rosenstock JG, Donaldson MH.

Cancer Treat Rep · clinical trial; research support, u.s. gov't, p.h.s.; randomized controlled trial; journal article